CT053PTSA
PCD-DCT053-16-002
Phase 1 small_molecule terminated
Quick answer
CT053PTSA for Acute Myeloid Leukemia (AML) is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Acute Myeloid Leukemia (AML)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated